Ultimovacs ASA

OB:ZLNA Stock Report

Market Cap: NOK 390.8m

Ultimovacs Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZLNA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders437,6440.216%
Institutions5,604,2812.77%
Private Companies10,364,9435.12%
General Public185,863,78591.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 487.9%.

Top Shareholders

Top 25 shareholders own 8.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.21%
GJELSTEN HOLDING AS
6,495,866NOK 12.6m0%no data
0.84%
Canica AS
1,705,957NOK 3.3m0%0.01%
0.75%
RADFORSK
1,519,263NOK 2.9m0%4.45%
0.68%
Inven2 AS
1,372,163NOK 2.7m0%no data
0.32%
Nordea Investment Management, AB
648,080NOK 1.3m0%no data
0.29%
Stavanger Forvaltning AS
583,416NOK 1.1m0%no data
0.28%
Danske Invest Asset Management AS
563,525NOK 1.1m0%0.04%
0.26%
Prieta As
533,988NOK 1.0m0%no data
0.2%
Langøya Invest As
400,000NOK 772.8k0%no data
0.2%
Myrlid AS
400,000NOK 772.8k0%no data
0.19%
Handelsbanken Asset Management
381,633NOK 737.3k0%no data
0.17%
Folketrygdfondet
343,465NOK 663.6k0%no data
0.15%
Sissener AS
300,000NOK 579.6k0%0.02%
0.12%
Wiarom As
250,000NOK 483.0k0%no data
0.12%
Leif Gade
240,000NOK 463.7k0%no data
0.1%
Jakob Hatteland Holding AS
211,110NOK 407.9k0%no data
0.07%
Storebrand Asset Management AS
142,358NOK 275.0k0%no data
0.045%
Leiv Askvig
91,500NOK 176.8k0%no data
0.043%
Æolus As
87,500NOK 169.1k0%no data
0.028%
Hans Eid
57,200NOK 110.5k0%no data
0.015%
Fireh AS
30,900NOK 59.7k0%no data
0.013%
Carlos de Sousa
26,056NOK 50.3k0%no data
0.0033%
Kari Gronas
6,640NOK 12.8k0%no data
0.0032%
Eva Dugstad
6,400NOK 12.3k0%no data
0.0026%
Jonas Einarsson
5,300NOK 10.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/28 23:22
End of Day Share Price 2025/03/28 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ultimovacs ASA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Geir HolomDNB Markets